HUTCHMED (Germany) Performance
| H7T2 Stock | EUR 2.72 0.10 3.55% |
The company retains a Market Volatility (i.e., Beta) of 0.0813, which attests to not very significant fluctuations relative to the market. As returns on the market increase, HUTCHMED's returns are expected to increase less than the market. However, during the bear market, the loss of holding HUTCHMED is expected to be smaller as well. At this point, HUTCHMED LS 1 has a negative expected return of -0.0192%. Please make sure to check out HUTCHMED's maximum drawdown, potential upside, and the relationship between the treynor ratio and value at risk , to decide if HUTCHMED LS 1 performance from the past will be repeated at some future point.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days HUTCHMED LS 1 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, HUTCHMED is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
HUTCHMED |
HUTCHMED Relative Risk vs. Return Landscape
If you would invest 290.00 in HUTCHMED LS 1 on September 21, 2024 and sell it today you would lose (18.00) from holding HUTCHMED LS 1 or give up 6.21% of portfolio value over 90 days. HUTCHMED LS 1 is producing return of less than zero assuming 4.0871% volatility of returns over the 90 days investment horizon. Simply put, 36% of all stocks have less volatile historical return distribution than HUTCHMED, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
HUTCHMED Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for HUTCHMED's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as HUTCHMED LS 1, and traders can use it to determine the average amount a HUTCHMED's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0047
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | H7T2 |
Estimated Market Risk
| 4.09 actual daily | 36 64% of assets are more volatile |
Expected Return
| -0.02 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average HUTCHMED is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of HUTCHMED by adding HUTCHMED to a well-diversified portfolio.
HUTCHMED Fundamentals Growth
HUTCHMED Stock prices reflect investors' perceptions of the future prospects and financial health of HUTCHMED, and HUTCHMED fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on HUTCHMED Stock performance.
| Return On Equity | -0.25 | |||
| Return On Asset | -0.19 | |||
| Profit Margin | (0.64) % | |||
| Operating Margin | (0.95) % | |||
| Shares Outstanding | 864.77 M | |||
| Revenue | 400.81 M | |||
| EBITDA | (373.29 M) | |||
| Cash And Equivalents | 950.45 M | |||
| Cash Per Share | 1.13 X | |||
| Total Debt | 36.69 M | |||
| Debt To Equity | 0.04 % | |||
| Book Value Per Share | 0.95 X | |||
| Cash Flow From Operations | (105.01 M) | |||
| Earnings Per Share | (0.23) X | |||
About HUTCHMED Performance
By analyzing HUTCHMED's fundamental ratios, stakeholders can gain valuable insights into HUTCHMED's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if HUTCHMED has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if HUTCHMED has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
HUTCHMED Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases worldwide. HUTCHMED Limited was incorporated in 2000 and is headquartered in Central, Hong Kong. HUTCHMED operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 1280 people.Things to note about HUTCHMED LS 1 performance evaluation
Checking the ongoing alerts about HUTCHMED for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for HUTCHMED LS 1 help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| HUTCHMED LS 1 generated a negative expected return over the last 90 days | |
| HUTCHMED LS 1 has high historical volatility and very poor performance | |
| The company reported the revenue of 400.81 M. Net Loss for the year was (178.43 M) with loss before overhead, payroll, taxes, and interest of (201.19 M). | |
| HUTCHMED LS 1 has accumulated about 950.45 M in cash with (105.01 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.13. | |
| Roughly 45.0% of the company shares are held by company insiders |
- Analyzing HUTCHMED's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether HUTCHMED's stock is overvalued or undervalued compared to its peers.
- Examining HUTCHMED's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating HUTCHMED's management team can have a significant impact on its success or failure. Reviewing the track record and experience of HUTCHMED's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of HUTCHMED's stock. These opinions can provide insight into HUTCHMED's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for HUTCHMED Stock analysis
When running HUTCHMED's price analysis, check to measure HUTCHMED's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HUTCHMED is operating at the current time. Most of HUTCHMED's value examination focuses on studying past and present price action to predict the probability of HUTCHMED's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HUTCHMED's price. Additionally, you may evaluate how the addition of HUTCHMED to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |